This article has Open Peer Review reports available.
Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis
© Djokovic et al; licensee BioMed Central Ltd. 2010
Received: 9 July 2010
Accepted: 23 November 2010
Published: 23 November 2010
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|9 Jul 2010||Submitted||Original manuscript|
|22 Aug 2010||Reviewed||Reviewer Report - Richard Sainson|
|7 Sep 2010||Reviewed||Reviewer Report - Andreas Fischer|
|1 Oct 2010||Author responded||Author comments - Ren Liu|
|Resubmission - Version 2|
|1 Oct 2010||Submitted||Manuscript version 2|
|28 Oct 2010||Author responded||Author comments - Ren Liu|
|Resubmission - Version 3|
|28 Oct 2010||Submitted||Manuscript version 3|
|23 Nov 2010||Editorially accepted|
|23 Nov 2010||Article published||10.1186/1471-2407-10-641|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.